Leila Marie Beeby v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2022)

Leila Marie Beeby filed a petition for compensation on October 9, 2020, alleging she suffered Guillain-Barre Syndrome (GBS) as a result of an influenza vaccine received on September 19, 2019. Petitioner alleged the vaccine was administered in the United States, that she experienced residual effects of her condition for more than six months, and that no civil action for damages had been brought.

Respondent denied that petitioner sustained a GBS Table injury, denied that the flu vaccine caused petitioner's alleged GBS or any other injury, and denied that her current condition was a sequela of a vaccine-related injury. Despite these denials, the parties filed a joint stipulation on May 10, 2022, agreeing that a decision should be entered awarding compensation.

Chief Special Master Brian H. Corcoran adopted the stipulation, awarding Leila Marie Beeby a lump sum of $147,800.00, payable to Petitioner, for all items of damages available under Section 15(a).

This amount represents a settlement of liability and damages. Petitioner was represented by Andrew Donald Downing of Van Cott & Talamante, PLLC.

Respondent was represented by Sarah Black Rifkin of the U.S. Department of Justice.